Top menu
Main menu
Main Content

You are here

PERK modulation for Huntington’s disease therapy

PERK modulation for Huntington’s disease therapy

Novel pharmacological approach for treating glycogen storage disorders

Modality: Small Molecules

Prof. Gerardo Z. Lederkremer, Shmunis School of Biomedicine and Cancer Research, Faculty of Life Sciences, TAU

Related researches >>

Related videos >>

Gallery >>

Explore

About Us

SPARK Educational Forum. Photo by National Cancer Institute on Unsplash

SPARK Educational Forum

SPARK Educational Forum. Photo by National >

SPARK Europe Webinar Series Spring 2022. Photo by Gabriel Benois on Unsplash

SPARK Europe Webinar Series Spring 2022

SPARK Europe Webinar Series Spring 2022 >

Quick Links

SPARK

SPARK TEL AVIV

Tel Aviv University makes every effort to respect copyright. If you own copyright to the content contained

here and / or the use of such content is in your opinion infringing, Contact us as soon as possible >>

Tel Aviv University, P.O. Box 39040, Tel Aviv 6997801, Israel